The assay was performed in a Waters 2695 HPLC equipped with a Waters
2996 detector (Waters Corporation, Milford, MA). Briefly, a mobile
phase (acetonitrile:water, 60:40 v/v) flowed isocratically through
a Xterra MS (reference 186000494) C18 HPLC column (250 × 4.6
mm, 5 μm) (Waters Corporation, Milford, MA) at a flow rate of
1 mL/min. The injection volume was 20 μL, and the wavelength
was 210 nm. The sample and column were maintained at 25 °C. The
limit of quantification (LOQ) of the analytical technique was set
at 0.1 ng/mL.
Fluorescein was quantified with a UV spectrophotometer
(VICTOR Multilabel Plate Reader, PerkinElmer, Waltham, MA) at the
wavelength of 485 nm.
Encapsulation efficiency, according to
the indirect method, was
calculated according to
amount of drug quantified in the filtrate (drug not encapsulated)
and WT the drug quantified in the total
formula. Liposomes were centrifuged in 100 kDa Amicon Ultra units
(Merck KGaA, Darmstadt, Germany) at 4500 rpm for 30 min.